BAYRY - Bayer wins Roundup trial in Missouri court ahead of Supreme Court move

Bayer (OTCPK:BAYRY) said on Friday that a Missouri court ruled in its favor in a trial regarding claims that its Roundup weedkiller causes cancer, which would mark a third consecutive court victory for the company in the U.S. Previously, three U.S. juries had found in favor of plaintiffs who said that the glyphosate-based weedkiller caused their cancer, awarding them hundreds of millions of dollars in damages. Bayer (OTCPK:BAYRY) shares -3.6% in early trading as the stock market shows broad losses. The verdict comes days before an eagerly anticipated Supreme Court announcement on whether it will hear Bayer's (OTCPK:BAYRY) bid to review an appeals court decision that upheld $25M in damages awarded to a California resident that had used Roundup. Bayer (OTCPK:BAYRY) has asked the Supreme Court to find that federal approval of Roundup's product label by the Environmental Protection Agency meant the suit could not be brought forward under California

For further details see:

Bayer wins Roundup trial in Missouri court ahead of Supreme Court move